(9β)-3-Hydroxyestra-1,3,5(10)-trien-17-one (1225-03-2)
| Identification |
| Properties |
| Safety Data |
| |
 |
Other Product
- 2-(1-Adamantyl)-3-hydroxyestra-1,3,5(10)-trien-17-one
- Androst-5-en-17-one, 3-((1-oxoheptyl)oxy)-, (3beta)-, mixt. with (17beta)-3-hydroxyestra-1,3,5(10)-trien-17-yl pentanoate
- (13α)-3-Hydroxyestra-1,3,5(10)-trien-17-one
- (8α)-3-Hydroxyestra-1,3,5(10)-trien-17-one
- (8α,9β)-3-Methoxyestra-1,3,5(10)-trien-17-one
- 3-hydroxyestra-1,3,5(10)-trien-16-one
- Androst-4-en-3-one, 17-((1-oxoheptyl)oxy)-, (17beta)-, mixt. with (17beta)-3-hydroxyestra-1,3,5(10)-trien-17-yl pentanoate
- (17beta)-17-hydroxyestra-1,3,5(10)-trien-3-yl 3-phenylpropanoate
- Glucopyranoside, (17b)-3-hydroxyestra-1,3,5(10)-trien-17-yl(9CI)
- 17-hydroxyestra-1,3,5(10)-trien-3-yl hexopyranoside
- 17-hydroxyestra-1,3,5(10)-trien-3-yl methanesulfonate
- (17beta)-17-hydroxyestra-1,3,5(10)-trien-3-yl propanoate
- (17beta)-3-hydroxyestra-1,3,5(10)-trien-17-yl dihydrogen phosphate
- 17-hydroxyestra-1,3,5(10)-trien-3-yl hydrogen sulfate
- b-D-Glucopyranosiduronic acid, (17b)-3-hydroxyestra-1,3,5(10)-trien-17-yl,sodium salt (1:1)
- 19-Norpregn-4-en-20-yn-3-one, 17-((1-oxoheptyl)oxy)-, (17alpha)-, mixt. with (17beta)-3-hydroxyestra-1,3,5(10)-trien-17-yl pentanoate
- Morphinan-6-one,17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-, [(3b)-3-hydroxyestra-1,3,5(10)-trien-17-ylidene]hydrazone,(5a)- (9CI)
- 9β,14α-Epoxy-3-methoxy-8,14-secoestra-1,3,5(10)-trien-17-one
- (8α,9β)-14β-Hydroxy-3-methoxyestra-1,3,5(10)-trien-17-one
- 1,2-Benzisothiazol-3(2H)-one,2-[[[(17b)-17-hydroxyestra-1,3,5(10)-trien-3-yl]oxy]methyl]-,1,1-dioxide (9CI)
